2 1 Shi Ji Jing Ji Bao Dao·2025-12-03 13:03Key Highlights - Moer Technology is set to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 5, 2025, following approval from the Shanghai Stock Exchange [1] - Fosun Pharma has received clinical trial approval for its innovative drug FXS887, aimed at treating advanced malignant solid tumors, with no similar small molecule inhibitors approved globally [1] - Degu Technology has terminated its major asset restructuring plans due to failure to reach an agreement on key terms with the transaction counterparties [1] - Baiwei Storage's second-largest shareholder, the National Integrated Circuit Industry Investment Fund II, reduced its stake by 4.646 million shares, representing 0.9955% of the total share capital, from 7.9033% to 6.9078% [2] - Guizhou Bai Ling's actual controller, Jiang Wei, is under investigation by the China Securities Regulatory Commission for insider trading and other violations, which does not affect the company's operations [3] - Chalco International's subsidiary has won a bid for a 3.03 billion yuan electrolytic aluminum project, which is expected to positively impact the company's future performance [4] - Grinda plans to invest approximately 79.999 million yuan in a strategic placement of shares in Muxi Integrated Circuit, representing 0.19% of the total share capital post-IPO [5] - Wanlong Optoelectronics is planning to acquire control of Zhejiang Zhongkong Information Industry Co., which is expected to constitute a major asset restructuring [7]